CLINICAL TRIAL OF A POTENTIATED DIKETOPIPERAZINE DERIVATIVE AS A PSYCHOPHARMACOLOGICAL AGENT FOR THE TREATMENT OF PSYCHOTIC PATIENTS.
D035843:Biomedical Research; D002389:Catatonia; D003863:Depression; D003866:Depressive Disorder; D054659:Diketopiperazines; D006801:Humans; D007970:Leukopenia; D010259:Paranoid Disorders; D010276:Parasympatholytics; D010600:Pharmacology; D010879:Piperazines; D011613:Psychotherapy; D011618:Psychotic Disorders; D014116:Toxicology; D014149:Tranquilizing Agents; D014282:Trihexyphenidyl
D054659:Diketopiperazines; D010276:Parasympatholytics; D010879:Piperazines; D014149:Tranquilizing Agents; D014282:Trihexyphenidyl
CATATONIA; CLINICAL RESEARCH; DEPRESSION; LEUKOPENIA; PARANOIA; PARASYMPATHOLYTICS; PHARMACOLOGY; PIPERAZINES; PSYCHOSES; PSYCHOTHERAPY; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIHEXYPHENIDYL